Harpoon Therapeutics, Inc.

NasdaqCM:HARP 株式レポート

時価総額:US$492.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Harpoon Therapeutics バランスシートの健全性

財務の健全性 基準チェック /56

Harpoon Therapeuticsの総株主資本は$4.5M 、総負債は$8.8Mで、負債比率は194.4%となります。総資産と総負債はそれぞれ$47.6Mと$43.0Mです。

主要情報

194.4%

負債資本比率

US$8.83m

負債

インタレスト・カバレッジ・レシオn/a
現金US$31.61m
エクイティUS$4.54m
負債合計US$43.04m
総資産US$47.58m

財務の健全性に関する最新情報

Harpoon Therapeutics (NASDAQ:HARP) Will Have To Spend Its Cash Wisely

Mar 11
Harpoon Therapeutics (NASDAQ:HARP) Will Have To Spend Its Cash Wisely

Here's Why We're A Bit Worried About Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Situation

Jul 30
Here's Why We're A Bit Worried About Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Situation

Is Harpoon Therapeutics (NASDAQ:HARP) In A Good Position To Invest In Growth?

Mar 08
Is Harpoon Therapeutics (NASDAQ:HARP) In A Good Position To Invest In Growth?

Recent updates

Improved Revenues Required Before Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock's 97% Jump Looks Justified

Jan 30
Improved Revenues Required Before Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock's 97% Jump Looks Justified

Harpoon Therapeutics, Inc. (NASDAQ:HARP) Looks Inexpensive After Falling 55% But Perhaps Not Attractive Enough

Oct 01
Harpoon Therapeutics, Inc. (NASDAQ:HARP) Looks Inexpensive After Falling 55% But Perhaps Not Attractive Enough

Analysts Just Made A Notable Upgrade To Their Harpoon Therapeutics, Inc. (NASDAQ:HARP) Forecasts

Aug 14
Analysts Just Made A Notable Upgrade To Their Harpoon Therapeutics, Inc. (NASDAQ:HARP) Forecasts

Forecast: Analysts Think Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Business Prospects Have Improved Drastically

May 28
Forecast: Analysts Think Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Business Prospects Have Improved Drastically

Harpoon Therapeutics (NASDAQ:HARP) Will Have To Spend Its Cash Wisely

Mar 11
Harpoon Therapeutics (NASDAQ:HARP) Will Have To Spend Its Cash Wisely

Harpoon Therapeutics appoints Luke Walker as CMO

Oct 04

Harpoon Therapeutics: A Well Undervalued Tri-Specific Oncology Player

Sep 01

Here's Why We're A Bit Worried About Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Situation

Jul 30
Here's Why We're A Bit Worried About Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Situation

Harpoon Therapeutics: A T-Cell Engager Platform And A Negative Enterprise Value Makes It A Candidate For My 'Bio Boom' Portfolio

Jul 07

Is Harpoon Therapeutics (NASDAQ:HARP) In A Good Position To Invest In Growth?

Mar 08
Is Harpoon Therapeutics (NASDAQ:HARP) In A Good Position To Invest In Growth?

We're Keeping An Eye On Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Rate

Nov 30
We're Keeping An Eye On Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Rate

Harpoon Therapeutics: A First Look

Sep 16

Harpoon shares slide after early-stage prostate cancer study data fails to impress

Jun 04

財務状況分析

短期負債: HARPの 短期資産 ( $34.3M ) が 短期負債 ( $18.1M ) を超えています。

長期負債: HARPの短期資産 ( $34.3M ) が 長期負債 ( $24.9M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: HARP総負債よりも多くの現金を保有しています。

負債の削減: HARPの負債対資本比率は、過去 5 年間で0%から194.4%に増加しました。


貸借対照表


キャッシュ・ランウェイ分析

過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。

安定したキャッシュランウェイ: HARPは、前回報告された フリーキャッシュフロー に基づいて5か月分の十分な キャッシュランウェイ を有していますが、その後追加の資本を調達しました。

キャッシュランウェイの予測: HARPフリーキャッシュフロー 推定値 に基づいて11か月間十分なキャッシュランウェイがあると予測されていますが、その後、追加の資本を調達しました。


健全な企業の発掘